Price $17.22 |
Market Cap
581.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
106.0
|
P/B
10.19
|
P/S
6.43
|
Dividend %
-
|
|
P/CF
31.0
|
P/FCF
-
|
Op. Cash Flow
-5.1K
|
FCF
-0.1
|
|
Op. Margin
7.40%
|
Net Margin
6.10%
|
ROE
11.20%
|
ROI
15.90%
|
|
ROA
8.90%
|
EPS Growth
-48.10%
|
Current Ratio
6.2
|
Debt/Equity
0.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co (BMY) | $68.73 | - | 2.90% | 148.62B | Strong Buy |
| Lannett Company, Inc. (LCI) | $4.72 | - | - | 186.5M | Strong Buy |
| La Jolla Pharmaceutical Compan (LJPC) | $3.74 | - | - | 113.5M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $4.95 | - | - | 1.59B | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $26.43 | - | - | 1.04B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
